Literature DB >> 12444106

A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications.

Patrick G Buckley1, Kiran K Mantripragada, Magdalena Benetkiewicz, Isabel Tapia-Páez, Teresita Diaz De Ståhl, Magnus Rosenquist, Haider Ali, Caroline Jarbo, Cecilía De Bustos, Carina Hirvelä, Birgitta Sinder Wilén, Ingegerd Fransson, Charlotte Thyr, Britt-Inger Johnsson, Carl E G Bruder, Uwe Menzel, Martin Hergersberg, Nils Mandahl, Elisabeth Blennow, Anna Wedell, David M Beare, John E Collins, Ian Dunham, Donna Albertson, Daniel Pinkel, Boris C Bastian, A Fawad Faruqi, Roger S Lasken, Koichi Ichimura, V Peter Collins, Jan P Dumanski.   

Abstract

We have constructed the first comprehensive microarray representing a human chromosome for analysis of DNA copy number variation. This chromosome 22 array covers 34.7 Mb, representing 1.1% of the genome, with an average resolution of 75 kb. To demonstrate the utility of the array, we have applied it to profile acral melanoma, dermatofibrosarcoma, DiGeorge syndrome and neurofibromatosis 2. We accurately diagnosed homozygous/heterozygous deletions, amplifications/gains, IGLV/IGLC locus instability, and breakpoints of an imbalanced translocation. We further identified the 14-3-3 eta isoform as a candidate tumor suppressor in glioblastoma. Two significant methodological advances in array construction were also developed and validated. These include a strictly sequence defined, repeat-free, and non-redundant strategy for array preparation. This approach allows an increase in array resolution and analysis of any locus; disregarding common repeats, genomic clone availability and sequence redundancy. In addition, we report that the application of phi29 DNA polymerase is advantageous in microarray preparation. A broad spectrum of issues in medical research and diagnostics can be approached using the array. This well annotated and gene-rich autosome contains numerous uncharacterized disease genes. It is therefore crucial to associate these genes to specific 22q-related conditions and this array will be instrumental towards this goal. Furthermore, comprehensive epigenetic profiling of 22q-located genes and high-resolution analysis of replication timing across the entire chromosome can be studied using our array.

Entities:  

Mesh:

Year:  2002        PMID: 12444106     DOI: 10.1093/hmg/11.25.3221

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

1.  Integrative epigenomic and genomic analysis of malignant pheochromocytoma.

Authors:  Johanna Sandgren; Robin Andersson; Alvaro Rada-Iglesias; Stefan Enroth; Goran Akerstrom; Jan P Dumanski; Jan Komorowski; Gunnar Westin; Claes Wadelius
Journal:  Exp Mol Med       Date:  2010-07-31       Impact factor: 8.718

2.  Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel.

Authors:  David L Barker; Mark S T Hansen; A Fawad Faruqi; Diane Giannola; Orlando R Irsula; Roger S Lasken; Martin Latterich; Vladimir Makarov; Arnold Oliphant; Jonathon H Pinter; Richard Shen; Irina Sleptsova; William Ziehler; Eric Lai
Journal:  Genome Res       Date:  2004-05       Impact factor: 9.043

3.  High-resolution molecular characterization of 15q11-q13 rearrangements by array comparative genomic hybridization (array CGH) with detection of gene dosage.

Authors:  Nicholas J Wang; Dahai Liu; Alexander S Parokonny; N Carolyn Schanen
Journal:  Am J Hum Genet       Date:  2004-06-11       Impact factor: 11.025

4.  Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles.

Authors:  Carl E G Bruder; Arkadiusz Piotrowski; Antoinet A C J Gijsbers; Robin Andersson; Stephen Erickson; Teresita Diaz de Ståhl; Uwe Menzel; Johanna Sandgren; Desiree von Tell; Andrzej Poplawski; Michael Crowley; Chiquito Crasto; E Christopher Partridge; Hemant Tiwari; David B Allison; Jan Komorowski; Gert-Jan B van Ommen; Dorret I Boomsma; Nancy L Pedersen; Johan T den Dunnen; Karin Wirdefeldt; Jan P Dumanski
Journal:  Am J Hum Genet       Date:  2008-02-14       Impact factor: 11.025

5.  Atypical amplification of chromosome region 22q12 in melanoma: A case report.

Authors:  Giuseppina Liguori; Monica Cantile; Francesca Collina; Laura Marra; Anna DE Chiara; Renato Franco; Michele Caraglia; Gerardo Botti; Mirella D'Andrea; Giovanni Francesco Nicoletti
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

Review 6.  Application of array-based comparative genomic hybridization to clinical diagnostics.

Authors:  Bassem A Bejjani; Lisa G Shaffer
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

7.  Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection.

Authors:  Kiran K Mantripragada; Patrick G Buckley; Caroline Jarbo; Uwe Menzel; Jan P Dumanski
Journal:  J Mol Med (Berl)       Date:  2003-06-27       Impact factor: 4.599

8.  Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.

Authors:  Pawandeep Dhami; Alison J Coffey; Stephen Abbs; Joris R Vermeesch; Jan P Dumanski; Karen J Woodward; Robert M Andrews; Cordelia Langford; David Vetrie
Journal:  Am J Hum Genet       Date:  2005-03-08       Impact factor: 11.025

9.  High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.

Authors:  Teresita Díaz de Ståhl; Caisa M Hansson; Cecilia de Bustos; Kiran K Mantripragada; Arkadiusz Piotrowski; Magdalena Benetkiewicz; Caroline Jarbo; Leif Wiklund; Tiit Mathiesen; Gunnar Nyberg; V Peter Collins; D Gareth Evans; Koichi Ichimura; Jan P Dumanski
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

10.  Identification of copy number variants defining genomic differences among major human groups.

Authors:  Lluís Armengol; Sergi Villatoro; Juan R González; Lorena Pantano; Manel García-Aragonés; Raquel Rabionet; Mario Cáceres; Xavier Estivill
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.